Clinical efficacy of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine (PMPDAP) in the treatment of feline immunodeficiency virus-infected cats.
about
Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting.Antiviral treatment of feline immunodeficiency virus-infected cats with (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine.Efficacy and adverse effects of (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine in feline immunodeficiency virus-infected cats.
P2860
Clinical efficacy of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine (PMPDAP) in the treatment of feline immunodeficiency virus-infected cats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@en
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@nl
type
label
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@en
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@nl
prefLabel
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@en
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@nl
P2093
P2860
P356
P1476
Clinical efficacy of the acycl ...... eficiency virus-infected cats.
@en
P2093
Anja D Hartmann
Jan Balzarini
Natalie Wilhelm
P2860
P304
P356
10.1177/1098612X11431040
P577
2012-02-01T00:00:00Z